SEC Form 4 · accession 0001209191-18-048366
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H. Reilly
Officer — SVP & Chief Operating Officer
Period of report
Aug 23, 2018
Accepted (ET)
Aug 24, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 23, 2018 | M | 25,000 | $4.71 | A | 39,177 | D | |
| Common Stock | Aug 23, 2018 | S | 25,000 | $10.00 | D | 14,177 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $4.71 | Aug 23, 2018 | M | 25,000 | D | — | Dec 3, 2025 | Common Stock | 25,000 | 42,400 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016.
- F2This option vested 25% on December 14, 2016 and then in quarterly installments over 3 years thereafter.